A prospective study of xenon arc photocoagulation for central retinal vein occlusion

Donald R. May, Michael Klein, Gholam A. Peyman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Twenty patients with central retinal vein occlusion were randomly divided into two groups in a prospective study to evaluate the effects of xenon arc photocoagulation in central retinal vein occlusion. The patients in one group were treated with 3600 scatter xenon photocoagulation and the others received no treatment. The average follow-up was I8 months. There were no cases of rubeosis or neovascular glaucoma in the treated group. Two patients in the untreated group developed rubeosis with subsequent neovascular glaucoma. There was no significant difference in the visual prognosis or in fundus neovascularization between the groups.

Original languageEnglish (US)
Pages (from-to)816-818
Number of pages3
JournalBritish Journal of Ophthalmology
Volume60
Issue number12
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Retinal Vein
Retinal Vein Occlusion
Xenon
Light Coagulation
Neovascular Glaucoma
Prospective Studies
Therapeutics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine
  • Ophthalmology

Cite this

A prospective study of xenon arc photocoagulation for central retinal vein occlusion. / May, Donald R.; Klein, Michael; Peyman, Gholam A.

In: British Journal of Ophthalmology, Vol. 60, No. 12, 1976, p. 816-818.

Research output: Contribution to journalArticle

@article{9b2321db9e15488cb150590fd1251b19,
title = "A prospective study of xenon arc photocoagulation for central retinal vein occlusion",
abstract = "Twenty patients with central retinal vein occlusion were randomly divided into two groups in a prospective study to evaluate the effects of xenon arc photocoagulation in central retinal vein occlusion. The patients in one group were treated with 3600 scatter xenon photocoagulation and the others received no treatment. The average follow-up was I8 months. There were no cases of rubeosis or neovascular glaucoma in the treated group. Two patients in the untreated group developed rubeosis with subsequent neovascular glaucoma. There was no significant difference in the visual prognosis or in fundus neovascularization between the groups.",
author = "May, {Donald R.} and Michael Klein and Peyman, {Gholam A.}",
year = "1976",
doi = "10.1136/bjo.60.12.816",
language = "English (US)",
volume = "60",
pages = "816--818",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - A prospective study of xenon arc photocoagulation for central retinal vein occlusion

AU - May, Donald R.

AU - Klein, Michael

AU - Peyman, Gholam A.

PY - 1976

Y1 - 1976

N2 - Twenty patients with central retinal vein occlusion were randomly divided into two groups in a prospective study to evaluate the effects of xenon arc photocoagulation in central retinal vein occlusion. The patients in one group were treated with 3600 scatter xenon photocoagulation and the others received no treatment. The average follow-up was I8 months. There were no cases of rubeosis or neovascular glaucoma in the treated group. Two patients in the untreated group developed rubeosis with subsequent neovascular glaucoma. There was no significant difference in the visual prognosis or in fundus neovascularization between the groups.

AB - Twenty patients with central retinal vein occlusion were randomly divided into two groups in a prospective study to evaluate the effects of xenon arc photocoagulation in central retinal vein occlusion. The patients in one group were treated with 3600 scatter xenon photocoagulation and the others received no treatment. The average follow-up was I8 months. There were no cases of rubeosis or neovascular glaucoma in the treated group. Two patients in the untreated group developed rubeosis with subsequent neovascular glaucoma. There was no significant difference in the visual prognosis or in fundus neovascularization between the groups.

UR - http://www.scopus.com/inward/record.url?scp=0017046414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017046414&partnerID=8YFLogxK

U2 - 10.1136/bjo.60.12.816

DO - 10.1136/bjo.60.12.816

M3 - Article

VL - 60

SP - 816

EP - 818

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 12

ER -